In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Hold rating on Madrigal Pharmaceuticals (MDGL – Research ...

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Altimmune (ALT – Research Report) yesterday and set a price target of ...

In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), ...

In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on TG Therapeutics (TGTX – Research Report), with a price target of $38.00. The company’s shares ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ironwood Pharma (IRWD – Research Report) and Centessa Pharmaceuticals (CNTA – Research Report).

See the top stocks recommended by analysts >> Nektar Therapeutics (NKTR) B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Nektar Therapeutics today and set a price target of $4.00.

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Cassava Sciences (NASDAQ:SAVA) on Tuesday, setting a price target of $108, which is approximately 55.62% above... Investing.com ...

Stephanie Diaz; Investor Relations Manager; Viking Therapeutics Inc. Brian Lian; President, Chief Executive Officer, Director; Viking Therapeutics Inc. Greg Zante; C ...

Earlier, Mayank Yadav also missed the South Africa's tour due to back injury and also didn't play the Syed Mushtaq Ali Trophy and Vijay Hazare Trophy. India's Mayank Yadav set to miss the white ...